InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Silberman David, Chief Financial Officer. Officer active across 1 companies, notably Oramed Pharmaceuticals INC.. In total, 4 filings have been published. The latest transaction was disclosed on 1 September 2021 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations4 total
19,000 shares
Common Stock
SEC:0001213900-22-000805:0·
19,000 shares
Common Stock
SEC:0001213900-22-000805·
050,000 shares0
Common Stock
SEC:0001213900-21-046413·
050,000 shares0
Common Stock
SEC:0001213900-21-046413:0·
4 of 4 declarations
About Silberman David
David Silberman is the Chief Financial Officer at ORAMED PHARMACEUTICALS INC. He is responsible for the financial management of the company, overseeing financial planning and analysis. Silberman plays a key role in financial strategy and decision-making that influences ORAMED's performance.
